Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.

Emami KH, Brown LG, Pitts TE, Sun X, Vessella RL, Corey E.

Prostate. 2009 Oct 1;69(14):1481-92. doi: 10.1002/pros.20998.

2.

When prostate cancer meets bone: control by wnts.

Emami KH, Corey E.

Cancer Lett. 2007 Aug 18;253(2):170-9. Epub 2007 Apr 25. Review.

PMID:
17462819
3.

Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).

Uckun FM, Dibirdik I, Qazi S, Vassilev A, Ma H, Mao C, Benyumov A, Emami KH.

Bioorg Med Chem. 2007 Jan 15;15(2):800-14. Epub 2006 Oct 26.

PMID:
17098432
4.

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7. Epub 2004 Aug 16. Erratum in: Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16707.

5.

The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes.

Smale ST, Jain A, Kaufmann J, Emami KH, Lo K, Garraway IP.

Cold Spring Harb Symp Quant Biol. 1998;63:21-31. Review. No abstract available.

PMID:
10384267
6.

The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts.

Kumagai A, Guo Z, Emami KH, Wang SX, Dunphy WG.

J Cell Biol. 1998 Sep 21;142(6):1559-69.

7.
9.

Core promoter specificities of the Sp1 and VP16 transcriptional activation domains.

Emami KH, Navarre WW, Smale ST.

Mol Cell Biol. 1995 Nov;15(11):5906-16.

10.

Supplemental Content

Loading ...
Support Center